ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development

Overview of attention for article published in Journal of Hematology & Oncology, November 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet
blogs: 3 blogs
policy: 1 policy source

twitter: 2 X users
patent: 3 patents
wikipedia: 1 Wikipedia page

Readers on

mendeley: 320 Mendeley

Summary News Blogs Policy documents X Patents Wikipedia

So far, Altmetric has seen 3 patents that reference this research output.

Selective Bfl-1 peptides

Grant US-11198715-B2

United States of America

Selective Mcl-1 binding peptides

Grant US-11142554-B2

United States of America

METHODS FOR TREATING CANCER USING HSP90 INHIBITORS

Application WO-2018144680-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.